Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark J. Foley currently holds 995,935 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark J. Foley has been a net seller of RVNC stock. They have purchased $1.3M and sold $28.9M worth of shares.
Mark J. Foley's most recent insider trade was on Jun 30, 2024, when they sold 1,000 shares at $2.18 per share.
Mark J. Foley serves as Executive at Revance Therapeutics, Inc. (RVNC). They have executed 198 insider transactions totaling $30.2M over their tenure at the company.
Mark J. Foley holds the position of Executive at Revance Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Mark J. Foley has shown a selling trading pattern, with $1.3M in total purchases and $28.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark J. Foley was on Sep 30, 2020, when they sold $3.6M worth of RVNC shares. This transaction involved 143,269 shares at $25.14 per share.
Mark J. Foley currently owns 995,935 shares of Revance Therapeutics, Inc. (RVNC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark J. Foley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark J. Foley has 198 Form 4 filings on record as an insider at Revance Therapeutics, Inc..
Set alerts for Mark J. Foley and 40,000+ other insiders.